Indication
For the treatment of seizures associated with Lennox-Gastaut syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older.
Medicine details
- Medicine name:
- fenfluramine (Fintepla)
- SMC ID:
- SMC2723
- Pharmaceutical company
- UCB Pharma Ltd
- BNF chapter
- Central nervous system
- Submission type
- Full
- Publication due date:
- 10 February 2025
- Patient group submission deadline:
- 02 December 2024